0000899866-20-000098.txt : 20201221
0000899866-20-000098.hdr.sgml : 20201221
20201221170035
ACCESSION NUMBER: 0000899866-20-000098
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20201217
FILED AS OF DATE: 20201221
DATE AS OF CHANGE: 20201221
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Bazarko Daniel
CENTRAL INDEX KEY: 0001768214
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 000-27756
FILM NUMBER: 201404915
MAIL ADDRESS:
STREET 1: C/O ALEXION PHARMACEUTICALS, INC.
STREET 2: 121 SEAPORT BOULEVARD
CITY: BOSTON
STATE: MA
ZIP: 02210
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: ALEXION PHARMACEUTICALS, INC.
CENTRAL INDEX KEY: 0000899866
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 133648318
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 121 SEAPORT BOULEVARD
CITY: BOSTON
STATE: MA
ZIP: 02210
BUSINESS PHONE: 4752302596
MAIL ADDRESS:
STREET 1: 121 SEAPORT BOULEVARD
CITY: BOSTON
STATE: MA
ZIP: 02210
FORMER COMPANY:
FORMER CONFORMED NAME: ALEXION PHARMACEUTICALS INC
DATE OF NAME CHANGE: 19960111
4
1
wf-form4_160858802064948.xml
FORM 4
X0306
4
2020-12-17
0
0000899866
ALEXION PHARMACEUTICALS, INC.
ALXN
0001768214
Bazarko Daniel
C/O ALEXION PHARMACEUTICALS, INC.
121 SEAPORT BOULEVARD
BOSTON
MA
02210
0
1
0
0
SVP, Controller, CAO
Common Stock, par value $.0001 per share
2020-12-17
4
M
0
13066
97.58
A
43949
D
Common Stock, par value $.0001 per share
2020-12-17
4
M
0
11000
140.16
A
54949
D
Common Stock, par value $.0001 per share
2020-12-17
4
S
0
9900
157.59
D
45049
D
Common Stock, par value $.0001 per share
2020-12-17
4
S
0
13066
157.76
D
31983
D
Common Stock, par value $.0001 per share
2020-12-17
4
S
0
1100
158
D
30883
D
Common Stock
97.58
2020-12-17
4
M
0
13066
0
D
2023-06-01
Common Stock, par value $.0001 per share
13066.0
0
D
Common Stock
140.16
2020-12-17
4
M
0
11000
0
D
2026-02-28
Common Stock, par value $.0001 per share
11000.0
0
D
This transaction was executed in multiple trades through a broker-dealer at prices ranging from $157.75 - $157.79. The price reported in this column reflects the weighted average sales price. Upon request, the reporting person will provide to the SEC staff full information regarding the number of shares sold at each price.
Beginning June 1, 2013, options became exercisable 25% after one year and 1/16 every three months thereafter until fully vested over 4 years.
Beginning February 26, 2016, options became exercisable 25% after one year and 1/16 every three months thereafter until fully vested over 4 years.
/s/ Douglas Barry, Attorney-in-Fact for Daniel Bazarko
2020-12-21